Clinical Trials Browser

Phase 2/3 × Carcinoma, Hepatocellular × atezolizumab × Clear all

NCT07293468 2026-04-09

BIIRTH

Phase 2/3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05665348 2026-03-09

TRIPLET

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT07285850 2025-12-16

ABATE-MASLD

Phase 2/3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06109272 2025-08-15

LIVIGNO-2

Phase 2/3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular